펜실베이니아의 천식 임상 시험
천식 관련 연구 12개가 펜실베이니아 내 여러 지역에서 참여자를 모집하고 있습니다.
펜실베이니아의 도시
공식 연구 텍스트(영어)
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
피험자 모집 중3상
12세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07782996Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Pittsburgh
피험자 모집 중3상
12세 ~ 17세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06307665A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research Associates of Central PA, LLC, DuBois
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06977581A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- University of Pittsburgh Medical Center, Pittsburgh
- Allergy and Clinical Immunology Associates, Pittsburgh
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07219173A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma
- Allergy and Clinical Immunology Associates, Pittsburgh
피험자 모집 중3상
12세 ~ 80세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07869043Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Philadelphia
- Research Site, Smithfield
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06932263Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
피험자 모집 중건강한 지원자 환영
8세 ~ 70세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06512064A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, DuBois
- GSK Investigational Site, Wyomissing
피험자 모집 중3상
12세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT07456033Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
- The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT04743791A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Pittsburgh
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07532265A Study of CDX-622 in Participants With Mild to Moderate Asthma
- University of Pittsburgh Asthma and Environmental Lung Health Institute at UPMC, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT07330778Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT06979323ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.